129 related articles for article (PubMed ID: 1508295)
1. Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.
Heckers S; Geula C; Mesulam MM
Neurobiol Aging; 1992; 13(4):455-60. PubMed ID: 1508295
[TBL] [Abstract][Full Text] [Related]
2. Neurofibrillary tangles have no obligatory predilection for acetylcholinesterase-rich neurons.
Mesulam MM; Brimijoin S; Geula C
Neurobiol Aging; 1994; 15(5):615-9. PubMed ID: 7824053
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution.
Mesulam MM; Geula C
J Comp Neurol; 1991 Apr; 306(2):193-220. PubMed ID: 2050843
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase reactivity in the frontal cortex of human and monkey: contribution of AChE-rich pyramidal neurons.
Mrzljak L; Goldman-Rakic PS
J Comp Neurol; 1992 Oct; 324(2):261-81. PubMed ID: 1430332
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
Ransmayr G; Cervera P; Hirsch EC; Berger W; Fischer W; Agid Y
Neuroscience; 1992; 47(4):843-51. PubMed ID: 1374541
[TBL] [Abstract][Full Text] [Related]
6. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Coleman AE; Geula C; Price BH; Mesulam MM
Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
8. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
9. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG; Svendsen CN; Selkoe DJ
Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of acetylcholinesterase activity closely associated with amyloid beta/A4 protein is not correlated with acetylcholinesterase-positive fiber density in amygdala of Alzheimer's disease.
Nakamura S; Takemura M; Suenaga T; Akiguchi I; Kimura J; Yasuhara O; Kimura T; Kitaguchi N
Acta Neuropathol; 1992; 84(4):425-32. PubMed ID: 1441923
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.
Hof PR; Morrison JH
J Comp Neurol; 1990 Nov; 301(1):55-64. PubMed ID: 1706358
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase provides deeper insights into Alzheimer's disease.
Shen ZX
Med Hypotheses; 1994 Jul; 43(1):21-30. PubMed ID: 7968717
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.
Gomez-Ramos P; Mufson EJ; Moran MA
Brain Res; 1992 Jan; 569(2):229-37. PubMed ID: 1540829
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
15. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.
Mesulam MM; Geula C
J Comp Neurol; 1988 Sep; 275(2):216-40. PubMed ID: 3220975
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Wright CI; Geula C; Mesulam MM
Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
[TBL] [Abstract][Full Text] [Related]
17. Molecular forms of acetylcholinesterases in Alzheimer's disease.
Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
19. Variations in Acetylcholinesterase Activity within Human Cortical Pyramidal Neurons Across Age and Cognitive Trajectories.
Janeczek M; Gefen T; Samimi M; Kim G; Weintraub S; Bigio E; Rogalski E; Mesulam MM; Geula C
Cereb Cortex; 2018 Apr; 28(4):1329-1337. PubMed ID: 28334147
[TBL] [Abstract][Full Text] [Related]
20. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
Shortridge BA; Vogel FS; Burger PC
Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
